Kevin Pethe PhD, MSc

Assoc Prof Kevin Pethe is an Associate Professor of Infectious Diseases in Lee Kong Chian School of Medicine, Nanyang Technological University. He obtained his PhD in genetics and molecular biology from Institut Pasteur, Lille II, and received his postdoctoral training in cellular microbiology at Cornell University. In 2004, Dr Pethe was appointed senior research investigator and project manager at the Novartis Institut for Tropical Diseases, Singapore, to work on small molecule drug discovery for tuberculosis. In 2011, he took a position of principal investigator at Institut Pasteur Korea to pursue his interest on host-pathogen interactions and chemical biology applied to tuberculosis and multidrug resistant bacteria. He was promoted to head of the department of disease biology & chemical genomics in 2013 and nominated acting CEO of Institut Pasteur Korea in the same year.

Dr Kevin Pethe is recognised for his contribution to the area of chemical genomics and drug discovery for tuberculosis. He has provided fundamental insights into the pathogenesis of Mycobacterium tuberculosis and on strategies to discover novel antibacterial agents. His professional experience includes evaluating research grants for the European Union and the French National Research Agency. He is a former director of the board of Institut Pasteur Korea and former member of a selection committee for the appointment of principal investigators at the Institut for Basic Science, Korea.